Michael B. Kastan is the executive director of the Duke Cancer Institute and professor of pharmacology and cancer biology. Kastan received his bachelor's...
3 KB (223 words) - 10:20, 7 April 2024
Lymphoma (redirect from B-cell lymphomas)
Tepper John E. Niederhuber, James O. Armitage, James H. Doroshow, Michael B. Kastan, Joel E. (2014). "Childhood lymphoma". Abeloff's clinical oncology...
67 KB (6,611 words) - 05:25, 15 August 2024
Mark S. Humayun Tyler Jacks Alexandra L. Joyner Frederick S. Kaplan Michael B. Kastan Ichiro Kawachi Isaac S. Kohane Uma R. Kotagal Story C. Landis Roger...
78 KB (9,527 words) - 21:12, 22 September 2024
damage has remained an important question that has been studied by Michael B. Kastan, Scott W. Lowe, Karen Vousden, and others. El-Deiry's contribution...
34 KB (3,588 words) - 06:02, 25 June 2024
decreasing the burden of cancer and accelerating scientific progress. Michael B. Kastan, a cancer scientist and Director of the Comprehensive Cancer Center...
8 KB (563 words) - 23:46, 1 August 2024
Niederhuber, John E.,, Armitage, James O., Doroshow, James H.,, Kastan, M. B. (Michael B.),, Tepper, Joel E.,, Preceded by: Abeloff, Martin D. (6th ed.)...
5 KB (666 words) - 12:14, 12 July 2024
elected to the National Academy of Medicine in 2009 alongside colleague Michael B. Kastan. The following year, Relling was the senior author of the "first genome-wide...
10 KB (903 words) - 16:09, 22 August 2024
University of Pennsylvania School of Medicine 2017 Michael Karin, PhD UC San Diego 2017 Michael B. Kastan, MD, PhD Duke University School of Medicine 2017...
25 KB (174 words) - 18:28, 14 June 2024
2017. Emily H-Y Cheng, David G Kirsch, Rollie J Clem, Rajani Ravi, Michael B Kastan, Atul Bedi, Kazuyoshi Ueno, J Marie Hardwick. Conversion of Bcl-2 to...
4 KB (459 words) - 18:57, 14 January 2024
Archived from the original on 2012-09-09. Retrieved 2012-08-26. Moding EJ, Kastan MB, Kirsch DG (2013). "Strategies for optimizing the response of cancer...
87 KB (8,529 words) - 19:32, 9 September 2024